Familial pituitary adenomas

被引:26
作者
Tichomirowa, M. A. [1 ]
Daly, A. F. [1 ]
Beckers, A. [1 ]
机构
[1] Univ Liege, Dept Endocrinol, Ctr Hosp Univ Liege, B-4000 Liege, Belgium
关键词
Carney's complex; familial isolated pituitary adenomas; multiple endocrine neoplasia type 1; pituitary adenoma; MULTIPLE-ENDOCRINE-NEOPLASIA; INTERACTING-PROTEIN GENE; TUMOR-SUPPRESSOR GENE; CYCLE INHIBITOR P27(KIP1); SUBUNIT TYPE 1A; TYPE-1; MEN; CARNEY COMPLEX; MUTATION ANALYSIS; GROWTH SUPPRESSOR; CLINICAL-FEATURES;
D O I
10.1111/j.1365-2796.2009.02109.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The majority of pituitary adenomas occur sporadically, however, about 5% of all cases occur in a familial setting, of which over half are due to multiple endocrine neoplasia type 1 (MEN-1) and Carney's complex (CNC). Since the late 1990s we have described non-MEN1/CNC familial pituitary tumours that include all tumour phenotypes, a condition named familial isolated pituitary adenomas (FIPA). The clinical characteristics of FIPA vary from those of sporadic pituitary adenomas, as patients with FIPA have a younger age at diagnosis and larger tumours. About 15% of FIPA patients have mutations in the aryl hydrocarbon receptor interacting protein gene (AIP), which indicates that FIPA may have a diverse genetic pathophysiology. This review describes the clinical features of familial pituitary adenomas like MEN1, the MEN 1-like syndrome MEN-4, CNC, FIPA, the tumour pathologies found in this setting and the genetic/molecular data that have been recently reported.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 50 条
  • [41] Innovations and controversies in the WHO classification of pituitary adenomas
    George Kontogeorgos
    Acta Neuropathologica, 2006, 111 : 73 - 75
  • [42] Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
    Beckers, Albert
    Aaltonen, Lauri A.
    Daly, Adrian F.
    Karhu, Auli
    ENDOCRINE REVIEWS, 2013, 34 (02) : 239 - 277
  • [43] Apoplexy in nonfunctioning pituitary adenomas
    Wildemberg, Luiz Eduardo
    Glezer, Andrea
    Bronstein, Marcello D.
    Gadelha, Monica R.
    PITUITARY, 2018, 21 (02) : 138 - 144
  • [44] Molecular pathology of the pituitary adenomas
    Naoko Sanno
    Robert Y. Osamura
    Endocrine Pathology, 1997, 8 : 137 - 142
  • [45] Pituitary adenomas in elderly patients
    Stalldecker, Graciela
    Ballarino, Carolina
    Diez, Sabrina
    Mallea-Gil, Maria Susana
    MEDICINA-BUENOS AIRES, 2019, 79 (03) : 191 - 196
  • [46] The history of the treatment of pituitary adenomas
    Nicholas F. Maartens
    Endocrine, 2005, 28 (1) : 9 - 26
  • [47] Giant Multilobulated Pituitary Adenomas
    Post, Kalmon D.
    Bederson, Joshua B.
    WORLD NEUROSURGERY, 2012, 77 (3-4) : 453 - 454
  • [48] Hyperprolactinaemia and pituitary adenomas in adolescence
    Dissaneevate, P
    Warne, GL
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1998, 11 (04) : 531 - 541
  • [49] Multimodal therapy of pituitary adenomas
    Oehlke, O.
    Shah, M.
    Seufert, J.
    Grosu, A. -L.
    ONKOLOGE, 2013, 19 (06): : 513 - 521
  • [50] Dopamine Agonists for Pituitary Adenomas
    Cooper, Odelia
    Greenman, Yona
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9